Business Development Manager (C-Further) in London

**Business Development Manager (Children and Young People’s Cancer/ C-Further)****Salary range:** £50,000-£59,000 plus**benefits****Reports to:** Senior Business Development Executive (Therapeutics) **Contract:** Permanent **Hours:** Full-time, 35 hours per week **Location:** Stratford, London. Office-based with high flexibility (1-2 days per week in the office). *There will also be occasional travel both within the UK and internationally in this role (circa 2-3 times per year).* **Closing date:** Sunday 25th October 2026 **Interview process:** Screening call followed by competency-based interview with task/presentation. **Interview dates:** Approximately w/c 2nd November 2026**At Cancer Research UK, we exist to beat cancer.**We have an exciting opportunity for a **Business Development Manager (BDM)** to join C-Further as part of Cancer Research Horizon’s Therapeutics BD team, which supports C-Further in its business strategy execution with industry, academia and partners. You’ll be expected to carry out critical business development activities relevant to C-Further’s broad commercialisation objectives, as it relates to all therapeutic technologies coming out of our network. A primary focus of this role is to lead the development and implementation of the BD and commercialisation strategy for the Children’s and Young People’s (CYP) cancers within the C-Further children’s cancer therapeutics consortium. You will work closely with internal and external stakeholders, building relationships with industry and the academic community to develop opportunities and executing research agreements for collaboration in the therapeutic discovery space. A desire to thrive in complex, multi-party time-sensitive contracting and negotiations whilst maintaining relationships is key. In addition, you will make considered contributions to the development of C-Further’s wider partnering strategy and critical new partnerships (e.g. with new consortium delivery partners and funders in the CYP ecosystem) and play an active role in the governance of the C-Further through participation in its joint management team. This role offers an excellent opportunity for the successful candidate to help drive C-Further's partnering strategy, and to make a major impact on the translation and commercialisation of exciting new technologies, for the benefit of cancer patients across the world. It also provides deep and broad exposure to technology transfer, intellectual property management, and business development and transactions, in a highly collaborative and high-profile initiative at the cutting edge of innovation. **About us** Cancer Research UK (CRUK) is the world's largest independent funder of oncology research, with an annual R&D spend of over £400 million, and a network of over 4,000 researchers at 90 institutions across the UK and beyond. Cancer Research Horizons (CRH) is the integrated innovation engine within CRUK, tasked with translating scientific breakthroughs into direct patient benefit. With exclusive rights to CRUK’s annual investment in world-class cancer research, we’re a powerful partner in the fight to conquer cancer, with an established track record, including early contributions to 14 therapeutics launched into the market. As the second largest oncology-tech licensor globally, we work closely with academia and industry to bridge the gap between research and the market, our focus always on beating cancer. The Business Development (BD) team within Cancer Research Horizon’s Commercial Partnerships (CP) unit provides the primary interface with industry and investors. Children and Young people’s cancer (CYP - <26>